MD Anderson Research Highlights for February 21, 2024
February 22, 2024
February 22, 2024
HOUSTON, Texas, Feb. 22 -- The University of Texas's MD Anderson Cancer Center issued the following news release:
* * *
Featuring insights into AML treatments, translational models for drug development, a novel role for p53, and therapeutic targets for breast cancer and multiple myeloma
* * *
The University of Texas MD Anderson Cancer Center's Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These . . .
* * *
Featuring insights into AML treatments, translational models for drug development, a novel role for p53, and therapeutic targets for breast cancer and multiple myeloma
* * *
The University of Texas MD Anderson Cancer Center's Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These . . .